ScoreWhy is Pfizer Ltd. ?
1
Poor long term growth as Net Sales has grown by an annual rate of 2.01% and Operating profit at 7.55% over the last 5 years
2
With ROE of 18.3, it has a Very Expensive valuation with a 5.9 Price to Book Value
- The stock is trading at a premium compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of -7.03%, its profits have risen by 15.2% ; the PEG ratio of the company is 2.1
- At the current price, the company has a high dividend yield of 3.3
3
Below par performance in long term as well as near term
- Along with generating -7.03% returns in the last 1 year, the stock has also underperformed BSE500 in the last 3 years, 1 year and 3 months
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Pfizer for you?
Medium Risk, Low Return
Absolute
Risk Adjusted
Volatility
Pfizer
20.5%
-0.25
28.65%
Sensex
-4.3%
0.43
11.83%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
2.39%
EBIT Growth (5y)
7.42%
EBIT to Interest (avg)
59.60
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
-0.69
Sales to Capital Employed (avg)
0.74
Tax Ratio
24.64%
Dividend Payout Ratio
119.20%
Pledged Shares
0
Institutional Holding
19.76%
ROCE (avg)
49.32%
ROE (avg)
18.68%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
29
Industry P/E
31
Price to Book Value
5.78
EV to EBIT
23.40
EV to EBITDA
21.85
EV to Capital Employed
16.48
EV to Sales
7.88
PEG Ratio
1.22
Dividend Yield
3.40%
ROCE (Latest)
63.46%
ROE (Latest)
19.81%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Sideways
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
No Trend
No Trend
OBV
Bullish
Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend8What is working for the Company
PAT(Latest six months)
At Rs 373.87 cr has Grown at 30.75%
ROCE(HY)
Highest at 24.41%
NET SALES(Q)
Highest at Rs 645.03 cr
-3What is not working for the Company
INVENTORY TURNOVER RATIO(HY)
Lowest at 4.75 times
DEBTORS TURNOVER RATIO(HY)
Lowest at 9.74 times
Loading Valuation Snapshot...
Here's what is working for Pfizer
Net Sales - Quarterly
Highest at Rs 645.03 cr and Grown
each quarter in the last five quartersMOJO Watch
Near term sales trend is very positive
Net Sales (Rs Cr)
Profit After Tax (PAT) - Latest six months
At Rs 373.87 cr has Grown at 30.75%
Year on Year (YoY)MOJO Watch
Near term PAT trend is positive
PAT (Rs Cr)
Here's what is not working for Pfizer
Inventory Turnover Ratio- Half Yearly
Lowest at 4.75 times and Fallen
each half year in the last five half yearly periodsMOJO Watch
Company's pace of selling inventory has slowed
Inventory Turnover Ratio
Debtors Turnover Ratio- Half Yearly
Lowest at 9.74 times
in the last five half yearly periodsMOJO Watch
Company's pace of settling its Debtors has slowed
Debtors Turnover Ratio
